Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kurokawa, K.
Right arrow Articles by Fukagawa, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kurokawa, K.
Right arrow Articles by Fukagawa, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: III1
© 2003 European Renal Association-European Dialysis and Transplant Association

Introduction

Introduction

Kiyoshi Kurokawa and Masafumi Fukagawa

The first 10% of the full text of this article appears below.

Secondary hyperparathyroidism is one of the major bone abnormalities that develops in patients on chronic dialysis therapy. Several new agents have been . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?